ReShape Lifesciences (RSLS) Institutional Ownership → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free RSLS Stock Alerts $0.18 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for ReShape Lifesciences (NASDAQ:RSLS)CurrentInstitutional OwnershipPercentage22.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$63.54KNumber ofInstitutional Sellers(last 12 months)0 Get RSLS Insider Trade Alerts Want to know when executives and insiders are buying or selling ReShape Lifesciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RSLS Institutional Buying and Selling by Quarter Ad Paradigm PressAI “wealth window” is closing June 25thToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… ReShape Lifesciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2023Armistice Capital LLC188,000$64K0.0%N/A5.449% 5/11/2022 GSA Capital Partners LLP36,490$43K0.0%N/A0.196% 11/15/2021Sassicaia Capital Advisers LLC10,000$29K0.1%N/A0.063% 8/17/2021Armistice Capital LLC816,527$4.08M0.1%N/A24.447% 8/16/2021State Street Corp109,999$550K0.0%N/A3.293% 8/13/2021Alpine Global Management LLC17,000$85K0.0%N/A0.509% 8/13/2021Geode Capital Management LLC23,277$116K0.0%N/A0.697% 8/13/2021Vanguard Group Inc.51,120$256K0.0%N/A1.531% (Data available from 1/1/2016 forward) RSLS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RSLS shares? During the previous two years, the following institutional investors and hedge funds held shares of ReShape Lifesciences shares: Armistice Capital LLC ($64K), GSA Capital Partners LLP ($43K).Learn more on RSLS's institutional investors. What percentage of ReShape Lifesciences stock is owned by institutional investors? 22.06% of ReShape Lifesciences stock is owned by institutional investors. Learn more on RSLS's institutional investor holdings. Which institutional investors have been buying ReShape Lifesciences stock? The following institutional investors have purchased ReShape Lifesciences stock in the last 24 months: Armistice Capital LLC ($188K), and GSA Capital Partners LLP ($36.49K). How much institutional buying is happening at ReShape Lifesciences? Institutional investors have bought a total of 224,490 shares in the last 24 months. This purchase volume represents approximately $2.22M in transactions. Related Companies: DYNT Major Shareholders INVO Major Shareholders TNON Major Shareholders BJDX Major Shareholders STSS Major Shareholders VERO Major Shareholders AFIB Major Shareholders AVGR Major Shareholders VAPO Major Shareholders VVOS Major Shareholders This page (NASDAQ:RSLS) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.